Literature DB >> 31924111

Mechanisms of liver fibrosis and its role in liver cancer.

Debanjan Dhar1, Jacopo Baglieri1, Tatiana Kisseleva2, David A Brenner1.   

Abstract

Entities:  

Keywords:  Liver fibrosis; PNPLA3; fibrosis regression; hepatic stellate cells; liver cancer; metabolic pathways; mitochondria

Mesh：

Substances：

Year:  2020        PMID： 31924111      PMCID： PMC7016420          DOI： 10.1177/1535370219898141

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN： 1535-3699


× No keyword cloud information.
  187 in total

1.  A preventable cancer.

Authors:  Lucas Laursen
Journal:  Nature       Date:  2014-12-04       Impact factor: 49.962

2.  Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent.

Authors:  Tomonori Aoyama; Yong-Han Paik; Sumio Watanabe; Benoît Laleu; Francesca Gaggini; Laetitia Fioraso-Cartier; Sophie Molango; Freddy Heitz; Cédric Merlot; Cédric Szyndralewiez; Patrick Page; David A Brenner
Journal:  Hepatology       Date:  2012-12       Impact factor: 17.425

3.  A feed-forward loop amplifies nutritional regulation of PNPLA3.

Authors:  Yongcheng Huang; Shaoqing He; John Zhong Li; Young-Kyo Seo; Timothy F Osborne; Jonathan C Cohen; Helen H Hobbs
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-12       Impact factor: 11.205

4.  miR-30c and miR-193 are a part of the TGF-β-dependent regulatory network controlling extracellular matrix genes in liver fibrosis.

Authors:  Sanchari Roy; Fabian Benz; David Vargas Cardenas; Mihael Vucur; Jeremie Gautheron; Anne Schneider; Claus Hellerbrand; Nicolas Pottier; Jan Alder; Frank Tacke; Christian Trautwein; Christoph Roderburg; Tom Luedde
Journal:  J Dig Dis       Date:  2015-09       Impact factor: 2.325

5.  Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice.

Authors:  Piotr Czochra; Borut Klopcic; Erik Meyer; Johannes Herkel; Jose Francisco Garcia-Lazaro; Florian Thieringer; Peter Schirmacher; Stefan Biesterfeld; Peter R Galle; Ansgar W Lohse; Stephan Kanzler
Journal:  J Hepatol       Date:  2006-05-30       Impact factor: 25.083

Review 6.  Retinoic acids and hepatic stellate cells in liver disease.

Authors:  Young-Sun Lee; Won-Il Jeong
Journal:  J Gastroenterol Hepatol       Date:  2012-03       Impact factor: 4.029

7.  Hepatic stellate cells preferentially expand allogeneic CD4+ CD25+ FoxP3+ regulatory T cells in an IL-2-dependent manner.

Authors:  Guoping Jiang; Horng-Ren Yang; Lianfu Wang; Gary M Wildey; John Fung; Shiguang Qian; Lina Lu
Journal:  Transplantation       Date:  2008-12-15       Impact factor: 4.939

Review 8.  Retinoids in biological control and cancer.

Authors:  Anthonise Louis Fields; Dianne Robert Soprano; Kenneth J Soprano
Journal:  J Cell Biochem       Date:  2007-11-01       Impact factor: 4.429

Review 9.  Angiogenesis in liver disease.

Authors:  Mercedes Fernández; David Semela; Jordi Bruix; Isabelle Colle; Massimo Pinzani; Jaume Bosch
Journal:  J Hepatol       Date:  2008-12-31       Impact factor: 25.083

Review 10.  The role of PNPLA3 in health and disease.

Authors:  Piero Pingitore; Stefano Romeo
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-06-20       Impact factor: 4.698
View more
  31 in total

1.  Significance of circulating tumor cells in the portal vein regarding metastases and vascular invasion in hepatocellular carcinoma patients.

Authors:  Xiaojuan Zhao; Jingge Zhao; Lianyuan Tao; Yujin Pan; Long Yang; Xijun Zhang; Jianjun Yuan; Haohui Zhu
Journal:  J Gastrointest Oncol       Date:  2021-12

2.  The Combination of Age, International Standardized Ratio, Albumin and γ-Glutamyl Transpeptidase (AIAG), Tumor Size and Alpha Fetoprotein (AFP) Stage as the Prognostic Model for Hepatitis B-Related Hepatocellular Carcinoma.

Authors:  Shuangchi Liu; Zhiduan Xu; Zhuling Fang; Dengyong Zhang; Zhongqiang Qin; Longfei Fan; Jiakang Duan; Hongxiang Yin; Yigang Zhang; Qing Pang; Yi Tan
Journal:  Int J Gen Med       Date:  2021-08-10

3.  [Screening and identification of key genes ATP1B3 and ENAH in the progression of hepatocellular carcinoma: based on data mining and clinical validation].

Authors:  X Yang; Y Li; D Wu; Y Ma; S Zhou
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-06-20

4.  Analysis of current status of quantitative detection of biomarkers for liver fibrosis in Clinical labs in China.

Authors:  Chao Zhang; Chuanbao Zhang
Journal:  J Clin Lab Anal       Date:  2022-05-19       Impact factor: 3.124

5.  Endothelin-1 in portal hypertension: The intricate role of hepatic stellate cells.

Authors:  Devaraj Ezhilarasan
Journal:  Exp Biol Med (Maywood)       Date:  2020-08-13

Review 6.  Liver fibrosis: Pathophysiology and clinical implications.

Authors:  Jennifer Berumen; Jacopo Baglieri; Tatiana Kisseleva; Kristin Mekeel
Journal:  WIREs Mech Dis       Date:  2020-07-26

7.  Complexation with Random Methyl-β-Cyclodextrin and (2-Hidroxypropyl)-β-Cyclodextrin Enhances In Vivo Anti-Fibrotic and Anti-Inflammatory Effects of Chrysin via the Inhibition of NF-κB and TGF-β1/Smad Signaling Pathways and Modulation of Hepatic Pro/Anti-Fibrotic miRNA.

Authors:  Alina Ciceu; Cornel Balta; Hidegard Herman; Sami Gharbia; Simona-Rebeca Ignat; Sorina Dinescu; Judit Váradi; Ferenc Fenyvesi; Szilvia Gyöngyösi; Anca Hermenean; Marieta Costache
Journal:  Int J Mol Sci       Date:  2021-02-13       Impact factor: 5.923

8.  The DEN and CCl4 -Induced Mouse Model of Fibrosis and Inflammation-Associated Hepatocellular Carcinoma.

Authors:  Takeki Uehara; Igor P Pogribny; Ivan Rusyn
Journal:  Curr Protoc       Date:  2021-08

9.  DNA methylation profile of liver of mice conceived by in vitro fertilization.

Authors:  Saúl Lira-Albarrán; Xiaowei Liu; Seok Hee Lee; Paolo Rinaudo
Journal:  J Dev Orig Health Dis       Date:  2021-06-14       Impact factor: 3.034

Review 10.  Immunmodulatory Treatment Strategies of Hepatocellular Carcinoma: From Checkpoint Inhibitors Now to an Integrated Approach in the Future.

Authors:  Matthias Ocker; Christian Mayr; Tobias Kiesslich; Sebastian Stintzing; Daniel Neureiter
Journal:  Cancers (Basel)       Date:  2021-03-29       Impact factor: 6.639
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.